Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis
Authors:
Open Access
- 13 February 2019
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-14
Abstract
Clear cell renal cell carcinoma (ccRCC) was the most aggressive histological type of renal cell carcinoma (RCC) and accounted for 70–80% of cases of all RCC. The aim of this study was to identify the potential biomarker in ccRCC and explore their underlying mechanisms. Four profile datasets were downloaded from the GEO database to identify DEGs. GO and KEGG analysis of DEGs were performed by DAVID. A protein–protein interaction (PPI) network was constructed to predict hub genes. The hub gene expression within ccRCC across multiple datasets and the overall survival analysis were investigated utilizing the Oncomine Platform and UALCAN dataset, separately. A meta-analysis was performed to explore the relationship between the hub genes: EGFR and ccRCC. 127 DEGs (55 upregulated genes and 72 downregulated genes) were identified from four profile datasets. Integrating the result from PPI network, Oncomine Platform, and survival analysis, EGFR, FLT1, and EDN1 were screened as key factors in the prognosis of ccRCC. GO and KEGG analysis revealed that 127 DEGs were mainly enriched in 21 terms and 4 pathways. The meta-analysis showed that there was a significant difference of EGFR expression between ccRCC tissues and normal tissues, and the expression of EGFR in patients with metastasis was higher. This study identified 3 importance genes (EGFR, FLT1, and EDN1) in ccRCC, and EGFR may be a potential prognostic biomarker and novel therapeutic target for ccRCC, especially patients with metastasis.Keywords
Funding Information
- National Prominent Chinese Medicine Doctor (2A21533, 81673781)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (2A21533, 81673781)
- National Natural Science Foundation of China (2A21533, 81673781)
This publication has 33 references indexed in Scilit:
- Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology2016
- Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell CarcinomaJournal of Cancer, 2015
- EGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinomaJournal of Biomedical Science, 2012
- Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinomaCancer, 2011
- Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinomaProceedings of the National Academy of Sciences, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell CarcinomaClinical Cancer Research, 2007
- Differential expression of EGFR and TGFα in VHL-mutated renal cell carcinomas of the clear cell type: implications for targeted therapeutic approachesTargeted Oncology, 2006
- Silencing of Epidermal Growth Factor Receptor Suppresses Hypoxia-Inducible Factor-2–Driven VHL−/− Renal CancerCancer Research, 2005
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002